Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease - Nature Aging
Using an in silico network-based discovery approach, the authors identified sildenafil as a repurposable drug for Alzheimer’s disease. Analyzing insurance claims data from over 7 million individuals, they found that sildenafil usage was associated with a reduced risk of Alzheimer’s disease...
www.nature.com
Well...at least you'll remember who you've done.
